Green tea polyphenols reduce autoimmune symptoms in a murine model for human Sjogren's syndrome and protect human salivary acinar cells from TNF-α-induced cytotoxicity

References

• Daniels TE, Wu AJ. Xerostomia—clinical evaluation and treatment in general practice. J Calif Dent Assoc 2000; 28: 933–941
   PubMedGoogle Scholar
• Fox RI. Sjögren's syndrome. Controversies and progress. Clin Lab Med 1997; 17: 431–444
   PubMed Web of Science ®Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH. European study group on classification criteria for Sjogren's syndrome. Classification criteria for Sjogren's syndrome: A revised version of the European criteria proposed by the American–European consensus group. Ann Rheum Dis 2002; 61: 554–558
   PubMed Web of Science ®Google Scholar
• Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA. Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome. J Immunol 1993; 150: 3615–3623
   PubMed Web of Science ®Google Scholar
• Carsons S. A review and update of Sjogren's syndrome: Manifestations, diagnosis, and treatment. Am J Manag Care 2001; 7(14 Suppl)S433–S434
   PubMedGoogle Scholar
• Zhang N. Epidemiological study of primary Sjogrne's syndrome in China. Chin Med J (Engl) 1995; 108: 787–788
   PubMedGoogle Scholar
• Yoshida S. Sjögren's syndrome. Nippon Rinsho 1999; 57: 360–363
   PubMedGoogle Scholar
• Miyasaka N. Epidemiology and pathogenesis of Sjögren's syndrome. Nippon Rinsho 1995; 53: 2367–2370
   PubMedGoogle Scholar
• Ikebe K, Nokubi T, Sajima H, Kobayashi S, Hata K, Ono T, Ettinger RL. Perception of dry mouth in a sample of community-dwelling older adults in Japan. Spec Care Dentist 2001; 21: 52–59
   PubMedGoogle Scholar
• Schein OD, Hochberg MC, Munoz B, Tielsch JM, Bandeen-Roche K, Provost T, Anhalt GJ, West S. Dry eye and dry mouth in the elderly: A population-based assessment. Arch Intern Med 1999; 159: 1359–1363
   PubMed Web of Science ®Google Scholar
• Billings RJ, Proskin HM, Moss ME. Xerostomia and associated factors in a community-dwelling adult population. Community Dent Oral Epidemiol 1996; 24: 312–316
   PubMed Web of Science ®Google Scholar
• Baudouin C, Pisella PJ, Brignole F. Current treatments of xerophthalmia in Sjögren's syndrome. Rev Med Int 2004; 25: 376–382
   PubMedGoogle Scholar
• Fox PC. Salivary enhancement therapies. Caries Res 2004; 38: 241–246
   PubMedGoogle Scholar
• Khurshudian AV. A pilot study to test the efficacy of oral administration of interferon-alpha lozenges to patients with Sjögren's syndrome. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2003; 95: 38–44
   PubMed Web of Science ®Google Scholar
• Ohno S, Suzuki T, Dohi Y. The effect of bakumondo-to on salivary secretion in Sjogren syndrome. Ryumachi 1990; 30: 10–16
   PubMedGoogle Scholar
• Zhao LJ, Li ZJ, Huang YY, Ti ZK, Chen Y. Experience on 60 cases of Sjogren's syndrome diagnosed and treated with traditional Chinese medicine. J Tradit Chin Med 1989; 9: 31–34
   PubMedGoogle Scholar
• Mukhtar H, Ahmad N. Tea polyphenols: Prevention of cancer and optimizing health. Am J Clin Nutr 2000; 71(6 Suppl)1698S–1702S, discussion 1703S–4S
   PubMed Web of Science ®Google Scholar
• Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 2002; 42: 25–54
   PubMed Web of Science ®Google Scholar
• Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection (review). Int J Oncol 2001; 18: 1307–1313
   PubMed Web of Science ®Google Scholar
• Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea—a review. J Am Coll Nutr 2006; 25: 79–99
   PubMed Web of Science ®Google Scholar
• Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H. A new function of green tea: Prevention of lifestyle-related diseases. Ann NY Acad Sci 2001; 928: 274–280
   PubMed Web of Science ®Google Scholar
• Hsu S, Dickinson D. Green tea: A new approach to managing oral manifestations of Sjogren's syndrome and skin manifestations of lupus. J Biochem Mol Biol 2006; 39: 229–239
   PubMedGoogle Scholar
• Hsu S, Dickinson D, Qin H, Lapp C, Lapp D, Borke J, Walsh DS, Bollag WB, Stoppler H, Yamamoto T, Osaki T, Schuster G. Inhibition of autoantigen expression by ( − )-epigallocatechin-3-gallate (the major constituent of green tea) in normal human cells. J Pharmacol Exp Ther 2005; 315: 805–811
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Hsu S, Lewis J, Wataha J, Dickinson D, Singh B, Bollag WB, Lockwood P, Ueta E, Osaki T, Schuster G. Green tea polyphenol causes differential oxidative environments in tumor versus normal epithelial cells. J Pharmacol Exp Ther 2003; 307: 230–236
   PubMed Web of Science ®Google Scholar
• Suganuma M, Sueoka E, Sueoka N, Okabe S, Fujiki H. Mechanisms of cancer prevention by tea polyphenols based on inhibition of TNF-alpha expression. Biofactors 2000; 13: 67–72
   PubMed Web of Science ®Google Scholar
• Fujiki H, Suganuma M, Kurusu M, Okabe S, Imayoshi Y, Taniguchi S, Yoshida T. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen. Mutat Res 2003; 523–524: 119–125
   PubMed Web of Science ®Google Scholar
• Balasubramanian S, Efimova T, Eckert RL. Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem 2002; 277: 1828–1836
   PubMedGoogle Scholar
• Yang CS, Lee MJ, Chen L. Human salivary tea catechin levels and catechin esterase activities: Implication in human cancer prevention studies. Cancer Epidemiol Biomarkers Prev 1999; 8: 83–89
   PubMed Web of Science ®Google Scholar
• Cha S, Peck AB, Humphreys-Beher MG. Progress in understanding autoimmune exocrinopathy using the non-obese diabetic mouse: An update. Crit Rev Oral Biol Med 2002; 13: 4–16
   Google Scholar
• Morbini P, Manzo A, Caporali R, Epis O, Villa C, Tinelli C, Solcia E, Montecucco C. Multilevel examination of minor salivary gland biopsy for Sjogren's syndrome significantly improves diagnostic performance of AECG classification criteria. Arthritis Res Ther 2005; 7: R343–R348
   PubMedGoogle Scholar
• Azuma M, Tamatani T, Kasai Y, Sato M. Immortalization of normal human salivary gland cells with duct-, myoepithelial-, acinar-, or squamous phenotype by transfection with SV40 ori-mutant deoxyribonucleic acid. Lab Invest 1993; 69: 24–42
   PubMedGoogle Scholar
• Guggenbuhl P, Veillard E, Quelvenec E, Jego P, Semana G, Jean S, Meadeb J, Chales G, Perdriger A. Analysis of TNFalpha microsatellites in 35 patients with primary Sjogren's syndrome. Joint Bone Spine 2000; 67: 290–295
   PubMed Web of Science ®Google Scholar
• Koski H, Janin A, Humphreys-Beher MG, Sorsa T, Malmstrom M, Konttinen YT. Tumor necrosis factor-alpha and receptors for it in labial salivary glands in Sjogren's syndrome. Clin Exp Rheumatol 2001; 19: 131–137
   PubMed Web of Science ®Google Scholar
• Kulkarni K, Selesniemi K, Brown TL. Interferon-gamma sensitizes the human salivary gland cell line, HSG, to tumor necrosis factor-alpha induced activation of dual apoptotic pathways. Apoptosis 2006, Oct 17; [Epub ahead of print]
   PubMedGoogle Scholar
• Yamamoto T, Staples J, Wataha J, Lewis J, Lockwood P, Schoenlein P, Rao S, Osaki T, Dickinson D, Kamatani T, Schuster G, Hsu S. Protective effects of EGCG on salivary gland cells treated with gamma-radiation or cis-platinum(II)diammine dichloride. Anticancer Res 2004; 24: 3065–3073
   PubMedGoogle Scholar
• Kim HP, Wang X, Zhang J, Suh GY, Benjamin IJ, Ryter SW, Choi AM. Heat shock protein-70 mediates the cytoprotective effect of carbon monoxide: Involvement of p38 beta MAPK and heat shock factor-1. J Immunol 2005; 175: 2622–2629
   PubMed Web of Science ®Google Scholar
• Liu J, Lin A. Role of JNK activation in apoptosis: A double-edged sword. Cell Res 2005; 15: 36–42
   PubMed Web of Science ®Google Scholar
• Lin A. Activation of the JNK signaling pathway: Breaking the brake on apoptosis. Bioessays 2003; 25: 17–24
   PubMed Web of Science ®Google Scholar
• Curtis CL, Harwood JL, Dent CM, Caterson B. Biological basis for the benefit of nutraceutical supplementation in arthritis. Drug Discov Today 2004; 9: 165–172
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Cerhan JR, Criswell LA, Merlino L, Mudano AS, Burma M, Folsom AR, Saag KG. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: Results from the Iowa women's health study. Arthritis Rheum 2002; 46: 83–91
   PubMed Web of Science ®Google Scholar
• Haqqi TM, Anthony DD, Gupta S, Ahmad N, Lee MS, Kumar GK, Mukhtar H. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc Natl Acad Sci USA 1999; 96: 4524–4529
   PubMed Web of Science ®Google Scholar
• Roca V, Rosignoli F, Calafat M, Leiros CP. Lack of nitric oxide-mediated regulation of amylase secretion stimulated by VIP in parotid glands of NOD mice. Int Immunopharmacol 2004; 4: 1837–1844
   PubMedGoogle Scholar
• Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 1998; 128: 2334–2340
   PubMed Web of Science ®Google Scholar
• Sayama K, Oguni I, Tsubura A, Tanaka S, Matsuzawa A. Inhibitory effects of autoimmune disease by green tea in MRL-Faslprcg/Faslprcg mice. In Vivo 2003; 17: 545–552
   PubMed Web of Science ®Google Scholar
• Slomiany BL, Slomiany A. Porphyromonas gingivalis lipopolysaccharide interferes with salivary mucin synthesis through inducible nitric oxide synthase activation by ERK and p38 kinase. Biochem Biophys Res Commun 2002; 297: 1149–1153
   PubMedGoogle Scholar
• Zentner MD, Lin HH, Wen X, Kim KJ, Ann DK. The amiloride-sensitive epithelial sodium channel alpha-subunit is transcriptionally down-regulated in rat parotid cells by the extracellular signal-regulated protein kinase pathway. J Biol Chem 1998; 273: 30770–30776
   PubMedGoogle Scholar
• Slomiany BL, Slomiany A. Nitric oxide interferes with salivary mucin synthesis: Involvement of ERK and p38 mitogen-activated protein kinase. Physiol Pharmacol 2002; 53: 325–336
   Google Scholar
• Brautigam VM, Frasier C, Nikodemova M, Watters JJ. Purinergic receptor modulation of BV-2 microglial cell activity: Potential involvement of p38 MAP kinase and CREB. J Neuroimmunol 2005; 166: 113–125
   PubMedGoogle Scholar
• Nakamura H, Kawakami A, Yamasaki S, Kawabe Y, Nakamura T, Eguchi K. Expression of mitogen activated protein kinases in labial salivary glands of patients with Sjogren's syndrome. Ann Rheum Dis 1999; 58: 382–385
   PubMedGoogle Scholar
• Morin CI, Huot J. Recent advances in stress signaling in cancer. Cancer Res 2004; 64: 1893–1898
   PubMedGoogle Scholar
• Vayalil PK, Elmets CA, Katiyar SK. Treatment of green tea polyphenols in hydrophilic cream prevents UVB-induced oxidation of lipids and proteins, depletion of antioxidant enzymes and phosphorylation of MAPK proteins in SKH-1 hairless mouse skin. Carcinogenesis 2003; 24: 927–936
   PubMed Web of Science ®Google Scholar
• Bubici C, Papa S, Pham CG, Zazzeroni F, Franzoso G. NF-kappaB and JNK: An intricate affair. Cell Cycle 2004; 3: 1524–1529
   PubMed Web of Science ®Google Scholar
• Nakano H, Nakajima A, Sakon-Komazawa S, Piao JH, Xue X, Okumura K. Reactive oxygen species mediate crosstalk between NF-kappaB and JNK. Cell Death Differ 2006; 13: 730–737
   PubMed Web of Science ®Google Scholar